Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,992.00
Bid: 1,990.00
Ask: 1,993.00
Change: -8.00 (-0.40%)
Spread: 3.00 (0.151%)
Open: 2,008.00
High: 2,012.00
Low: 1,990.00
Prev. Close: 2,000.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Banks, insurance dodge carnage as real estate stocks sink

Thu, 03rd Nov 2022 09:28

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

BANKS, INSURANCE DODGE CARNAGE AS REAL ESTATE STOCKS SINK (0818 GMT)

Europe's STOXX 600 is flashing red as signalled by earlier futures trading, last down 0.9% after U.S. markets took a battering on Wednesday.

Only two sectors are spared from the carnage; banks are up 0.3%, and insurance is up 0.2%.

The former is helped out by the Netherlands' largest bank ING Groep which has rallied 5.5% after reporting Q3 results and rolling out a share buyback plan worth 1.5 billion euros ($1.46 billion).

A 2.7% lift for BNP Paribas after Q3 profits topped forecasts can't hurt either.

The two banks are also helping to stem losses on the STOXX 600 and are the two biggest positive weights in the index. Meanwhile, insurer AXA is up 1.7%.

But the share price outperformer is Denmark-based IT consultancy company Netcompany , with shares rising 20.5% after some upbeat Q3 financials.

The UK's Hikma Pharmaceuticals, up 5.5%, is also helping lift the index after reiterating 2022 guidance in a trading statement.

Real estate stocks are down 2.5%, and in what is a familiar story in recent months. They're also the worst performing sector , followed closely by autos travel and tech, all down about 2%.

Dutch semiconductor maker ASML is providing the biggest drag on the broader STOXX 600, down 3.3%, as are Danish healthcare company Novo Nordisk and France's LVMH , down 1.6% and 1.7% respectively.

Thyssenkrupp shares are down 8.9% after Deutsche Bank cut the German submarine-to-steel group to "hold" from "buy", citing macroeconomic difficulties and an overly complex group structure.

ONE CENTRAL BANK DRAMA AFTER ANOTHER (0745 GMT)

So, Jerome Powell found a way to quiet the endless market chatter of a pivot even as he opened the door to smaller hikes.

Clearly the Fed chief doesn't want the bond market to rally so much that it eases U.S. financial conditions while inflation is still running hot. Ironically, the more bonds price in a pivot, the less inclined the Fed will be to give them one.

As a result, May Fed funds have shifted to 5.08% from 4.90% at end of last week, and there's less chance of a cut priced in by late next year. The yield curve bear-flattened and has not been this inverted since the turn of the century.

Now it's time for the Old Lady of Threadneedle Street to enter stage right and do her routine for the cameras. The Monetary Policy Report is out at noon (1200 GMT), followed by a news conference half an hour later streamed live on the Bank of England's website.

Markets are priced for a hike of 75 bps to 3.0%, which amazingly would be the highest since 2008. What happened to the goode olde days of 10%-plus?

Some are tipping 50 bps, but that would risk markets concluding the BoE isn't serious about taming inflation and spooking gilts again. Equally, 100 bps would just fan fears of a much deeper recession and an even bigger budget black hole.

In any event, the BoE is going to have to revise up its CPI forecasts and slash those for GDP, which will make for gloomy viewing compared to the comedy show that is government policy right now.

Other key developments that could influence markets on Thursday:

U.S. initial jobless claims seen at 220K

ISM service sector PMI is forecast at 55.5

Earnings include ConocoPhillips, Kellogg, Starbucks

STOXX POISED TO FALL AS MARKET DIGESTS FED, TURNS TO BOE (0739 GMT)

European stocks are set for a fall of 1.1% at the open, as the market continues to digest the "double-sided message" delivered by the Fed on Wednesday which saw U.S stocks shed 2.5% into the close after initially rising following an expected 75-bps rate hike.

Attention turns to the Bank of England's midday rate announcement. Market expectations centre on a similar hike of 75 bps - which would be the central bank's largest since 1989 as it battles the highest inflation in 40 years.

Earnings season continues, with euro zone's biggest lender BNP Paribas posting a higher-than-expected net profit in the third quarter.

German premium carmaker BMW has reported better than expected quarterly net profit - thanks to high car prices - but warned that rising inflation and interest rates would start to weigh on sales in the coming months.

Higher costs for energy and raw materials, as well as a weakening building materials market are behind a potential 10% drop in 2022 operating profit for the world's No. 2 cement maker Heidelberg Materials.

Meanwhile one of the biggest net losses in German corporate history of 40 billion euro ($39.3 billion has been unveiled by soon-to-be-nationalised gas importer Uniper.

More News
24 Feb 2022 10:31

TOP NEWS: Hikma Pharmaceutical records revenue growth and lifts payout

(Alliance News) - Hikma Pharmaceutical PLC on Thursday reported full-year revenue growth on a "strong" performance by its three business segments and lifted its shareholder payout.

Read more
24 Feb 2022 07:58

Hikma Pharmaceutical delivers year of 'solid growth' and 'strategic momentum'

(Sharecast News) - Drugmaker Hikma Pharmaceutical said on Thursday that it had delivered another successful year of "solid growth and continued strategic momentum", with both revenue and operating profits improving year-on-year.

Read more
24 Feb 2022 07:50

LONDON MARKET PRE-OPEN: Share buybacks for Lloyds Banking and Hikma

(Alliance News) - Stock prices in London are seen opening sharply lower, with the FTSE 100 called down almost 200 points, amid fear of a full-scale war in eastern Europe after Russia announced the beginning of a military operation in Ukraine.

Read more
17 Feb 2022 16:08

UK earnings, trading statements calendar - next 7 days

Friday 18 February  
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 21 February 
Bank of Cyprus Holdings PLCFull Year Results
Dechra Pharmaceuticals PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Tristel PLCTrading Statement
Wilmington PLCHalf Year Results
Tuesday 22 February 
Antofagasta PLCFull Year Results
Bank of Georgia Group PLCFull Year Results
Benchmark Holdings PLCQ1 Results
Blancco Technology Group PLCHalf Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Coca-Cola HBC AGFull Year Results
Hargreaves Lansdown PLCHalf Year Results
HSBC Holdings PLCFull Year Results (at 0400 GMT)
InterContinental Hotels Group PLCFull Year Results
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Synectics PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wednesday 23 February 
Aston Martin Lagonda Global Holdings PLCFull Year Results
Barclays PLCFull Year Results
Capital & Counties Properties PLCFull Year Results
CAP-XX LtdHalf Year Results
Georgia Capital PLCFull Year Results
International Personal Finance PLCFull Year Results
Irish Residential Properties REIT PLCFull Year Results
Metro Bank PLCFull Year Results
Hochschild Mining PLCFull Year Results
Photo-Me International PLCFull Year Results
Rio Tinto PLCFull Year Results
Seraphim Space Investment Trust PLCHalf Year Results
Ted Baker PLCTrading Statement
Unite Group PLCFull Year Results
Thursday 24 February 
Anglo American PLCFull Year Results
BAE Systems PLCFull Year Results
Centrica PLCFull Year Results
Conduit Holdings LtdFull Year Results
Derwent London PLCFull Year Results
Drax Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Inchcape PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Rathbone Group PLCFull Year Results
Ricardo PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
St James's Place PLCFull Year Results
Tremor International LtdFull Year Results
WPP PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
9 Feb 2022 09:48

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

Read more
3 Feb 2022 09:12

Hikma completes acquisition of Teligent's Canadian assets

Hikma completes acquisition of Teligent's Canadian assets

Read more
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.